Search bioRxiv⌕ Search

Biology subjects

Howard, T.

Publications and source records attributed to Howard, T..

5 recordsLinked to original sources

Morning Elevation in Insulin Enhances Afternoon Postprandial Insulin Action and Glucose Effectiveness

The second-meal phenomenon refers to the improved glycemic response to a subsequent identical meal. We previously showed that morning (AM) hyperinsulinemia is a key mediator, priming the liver for enhanced net hepatic glucose uptake (NHGU) and glycogen storage during an afternoon (PM) hyperinsulinemic-hyperglycemic clamp. Postprandial NHGU is regulated by three primary mechanisms: insulin action (IA), initiated by hyperinsulinemia; glucose effectiveness (GE), driven by hyperglycemia; and the portal glucose signal (PGS), a neurally-mediated signal activated by glucose delivery into the hepatoportal circulation. It remained unclear, however, which of these mechanisms govern the increase in PM NHGU following AM insulin exposure. To address this, dogs underwent an AM clamp with either a 4-hour hyperinsulinemic prime (Prime, n=8) or basal insulin delivery (No Prime, n=8). After a 1.5-hour rest, both groups underwent a PM hyperglycemic clamp with portal glucose delivery under basal insulin conditions to isolate the effects of an AM insulin prime on PM glucose-mediated hepatic signals (GE/the PGS). Mean PM NHGU was significantly greater in the Prime group (2.2 {+/-} 0.3 mg/kg/min) compared to the No Prime group (0.1 {+/-} 0.3 mg/kg/min, p=0.005), accompanied by augmented net glycolytic and glycogen flux. These findings indicate that morning insulin can enhance glucose-mediated PM NHGU independently of a rise in PM insulin. However, maximal second-meal NHGU also requires elevated PM insulin. Together, this suggests that strategically timed early-day insulin or insulinotropic interventions could potentially improve hepatic responsiveness in settings of impaired postprandial glycemic control, such as insulin resistance or diabetes. Article HighlightsO_LIElevated morning insulin primes the liver for enhanced afternoon net hepatic glucose uptake (NHGU), but it was unclear whether augmentation of insulin action (IA), glucose effectiveness (GE), or the portal glucose signal (PGS) mediates this effect. C_LIO_LIDogs underwent a morning euglycemic clamp with either elevated or basal insulin delivery, followed by an afternoon euinsulinemic-hyperglycemic clamp to isolate the effect of morning insulin priming on afternoon GE/PGS. C_LIO_LIMorning insulin priming enhanced afternoon NHGU via increased glucose-mediated mechanisms, though maximal afternoon NHGU also requires elevated afternoon insulin. C_LIO_LIThese findings identify mechanisms underlying insulin-induced hepatic metabolic memory, providing a framework to inform strategies improving postprandial glucose handling in diabetes. C_LI

physiology↗

Rational Design of Immunogenic Nanoparticles as a Platform for Enhanced Ovarian Cancer Immunotherapy in Mice

Ovarian cancer immunotherapy remains a challenge based on the "cold" tumor microenvironment. Herein we present a rational design to create immunogenic nanoparticles as a multi-agent platform that promotes immune response in a mouse model of ovarian cancer. The hybrid lipid-silica nanosystem is capable of co-loading four types of cargo molecules including a model antigen, nucleic acid-based adjuvant Cytosine-p-linked to Guanine (CpG, TLR3/9 agonist), lipid-based adjuvant (MPLA, TLR4 agonist) integrated into the lipid coat, and optionally a small molecule drug, such as the chemotherapeutic agent oxaliplatin, a well-established treatment for ovarian cancer. The optimization of the nanoplatform in terms of lipid composition, functionalized silica dendritic core formation, and final charge, as well as their compatibility with the complex loading profile highlights an opportunity for enhanced survival of mice with advanced ovarian cancer compared to monotherapy. Furthermore, intraperitoneal administration led to preferential accumulation within tumor-burdened tissues with selective accumulation in myeloid cells. High myeloid cell cytotoxicity negated the benefits of oxaliplatin. The inclusion of CpG in the nanoparticle formulation enhanced the survival of mice with ovarian cancer. To interpret these outcomes and guide future design, we also developed a mathematical model of nanoparticle-driven immune activation, which quantified treatment efficacy and identified key parameters governing tumor response. The presented hybrid nanoparticle i tunable, enabling delivery of alternative molecules therefore, thereby highlighting a promising platform for the treatment of peritoneal cancers. Graphical TOC O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=69 SRC="FIGDIR/small/657862v1_ufig1.gif" ALT="Figure 1000"> View larger version (26K): org.highwire.dtl.DTLVardef@1434599org.highwire.dtl.DTLVardef@18e79e6org.highwire.dtl.DTLVardef@e5285corg.highwire.dtl.DTLVardef@bcc604_HPS_FORMAT_FIGEXP M_FIG C_FIG

immunology↗

Hepatic Metabolic Memory Triggered by AM Exposure to Glucagon Alters Afternoon Glucose Metabolism

The Staub-Traugott effect, or second-meal phenomenon, describes improved glucose disposal after a second identical meal. We previously showed that morning hyperinsulinemia primes the liver to enhance afternoon net hepatic glucose uptake and glycogen storage. However, mixed meals trigger co-secretion of insulin and glucagon, and glucagon is traditionally viewed as opposing insulins hepatic actions. Whether glucagon modifies the persistence of insulins priming effects across sequential metabolic challenges is unknown. Therefore, we investigated whether morning hyperglucagonemia alters the ability of morning hyperinsulinemia to prime subsequent hepatic glucose metabolism. Conscious dogs underwent two pancreatic clamp periods separated by a 1.5h rest period. Endogenous insulin and glucagon were suppressed with somatostatin and replaced intraportally at defined rates. During a 4h morning hyperinsulinemic-euglycemic clamp, dogs received matched insulin prime infusions with either basal glucagon (AM INS; n=8) or elevated glucagon (AM INS+GCG; n=8). After the rest period, both groups underwent a 2.5h afternoon hyperinsulinemic-hyperglycemic clamp under identical hormonal conditions. Afternoon net hepatic glucose uptake, glycogen, glycolytic, and gluconeogenic flux rates were quantified using arteriovenous difference methods and [3-3H]-glucose tracer kinetics. Liver biopsies were collected before and after the afternoon clamp to assess gene transcription and protein regulators of hepatic glucose metabolism. During the afternoon clamp, despite matched insulin, glucagon, and glucose levels, net hepatic glucose uptake was 41% lower in AM INS+GCG (3.6{+/-}0.4 mg/kg/min) than in AM INS (6.1{+/-}0.6 mg/kg/min; p<0.003). This was accompanied by a trend toward incomplete suppression of hepatic glucose production in AM INS+GCG (1.4{+/-}0.4 mg/kg/min), whereas it was fully suppressed in the AM INS group (p=0.06). Direct glycogen synthesis was also 44% lower in AM INS+GCG (1.8{+/-}0.2 vs 3.2{+/-}0.7 mg/kg/min; p<0.015), along with reductions in net glycogen synthesis and glycolytic flux. Morning insulin with basal glucagon increased hepatic glucokinase mRNA and protein before the afternoon clamp, whereas concurrent glucagon prevented this induction. In summary, antecedent morning hyperglucagonemia attenuates insulin-mediated hepatic priming, reducing hepatic glucose flux during a later hyperinsulinemic-hyperglycemic challenge. These findings identify glucagon as a regulator of hepatic metabolic memory alongside insulin and demonstrate that early-day insulin-glucagon dynamics shape the livers response to subsequent challenges, providing mechanistic insight into postprandial glucose regulation and implications for metabolic health and diabetes risk. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=121 SRC="FIGDIR/small/639957v3_ufig1.gif" ALT="Figure 1"> View larger version (31K): org.highwire.dtl.DTLVardef@6d210org.highwire.dtl.DTLVardef@1c93840org.highwire.dtl.DTLVardef@18c0b49org.highwire.dtl.DTLVardef@138ee9f_HPS_FORMAT_FIGEXP M_FIG C_FIG

physiology↗

The PCR Simulator: an on-line application for teaching Design of Experiments and the polymerase chain reaction

Our PCR Simulator is a web-based application designed to introduce concepts of multi-factorial experimental design and support teaching of the polymerase chain reaction. Learners select experimental settings and receive results of their simulated reactions quickly, allowing rapid iteration between data generation and analysis. This enables the student to perform complex iterative experimental design strategies within a short teaching session. Here we provide a short overview of the user interface and underpinning model, and describe our experience using this tool in a teaching environment.

scientific communication and education↗

Proteomic Architecture of Human Coronary and Aortic Atherosclerosis

The inability to detect premature atherosclerosis significantly hinders implementation of personalized therapy to prevent coronary heart disease. A comprehensive understanding of arterial protein networks and how they change in early atherosclerosis could identify new biomarkers for disease detection and improved therapeutic targets. Here we describe the human arterial proteome and the proteomic features strongly associated with early atherosclerosis based on mass-spectrometry analysis of coronary artery and aortic specimens from 100 autopsied young adults (200 arterial specimens). Convex analysis of mixtures, differential dependent network modeling and bioinformatic analyses defined the composition, network re-wiring and likely regulatory features of the protein networks associated with early atherosclerosis. Among other things the results reveal major differences in mitochondrial protein mass between the coronary artery and distal aorta in both normal and atherosclerotic samples - highlighting the importance of anatomic specificity and dynamic network structures in in the study of arterial proteomics. The publicly available data resource and the description of the analysis pipeline establish a new foundation for understanding the proteomic architecture of atherosclerosis and provide a template for similar investigations of other chronic diseases characterized by multi-cellular tissue phenotypes.\n\nHighlightsO_LILC MS/MS analysis performed on 200 human aortic or coronary artery samples\nC_LIO_LINumerous proteins, networks, and regulatory pathways associated with early atherosclerosis\nC_LIO_LIMitochondrial proteins mass and selected metabolic regulatory pathways vary dramatically by disease status and anatomic location\nC_LIO_LIPublically available data resource and analytic pipeline are provided or described in detail\nC_LI

molecular biology↗